Latest Health News
Quanta Therapeutics Presents Positive Phase 1 Data for QTX3034, an Oral G12D-Preferring Multi-KRAS Inhibitor, in Patients with Advanced Solid Tumors
– QTX3034 monotherapy and the QTX3034-cetuximab combination demonstrated favorable safety profiles and…
PMV Pharmaceuticals Announces Updated Rezatapopt Monotherapy Interim Data From Ongoing PYNNACLE Phase 2 Trial Across Multiple Solid Tumors With a TP53 Y220C Mutation
October 24, 2025 11:39 ET | Source: PMV Pharmaceuticals, Inc. Data presented…
New Clinical Data Confirms Yomi Robotic System Enhances Efficiency in Dental Implant Surgery
October 23, 2025 13:48 ET | Source: Neocis MIAMI, Oct. 23, 2025…
Award-Winning Film An Inconvenient Study Sparks Global Debate on Vaccine Safety and Chronic Disease
AUSTIN, Texas, Oct. 23, 2025 (GLOBE NEWSWIRE) -- The award-winning film An Inconvenient…
Progyny, Inc. Announces Details for Its Third Quarter 2025 Results Report
October 23, 2025 13:08 ET | Source: Progyny, Inc. NEW YORK, Oct.…
HearAdvisor Announces New Guide on the Best Hearing Aids and Earplugs of 2025 with Expert Choice Awards
October 22, 2025 17:59 ET | Source: HearAdvisor Rockford, Il, Oct. 22,…
CVRx to Report Third Quarter 2025 Financial and Operating Results and Host Conference Call on Nov. 5, 2025
October 22, 2025 16:30 ET | Source: CVRx, Inc. MINNEAPOLIS, Oct. 22,…
Vor Bio to Host Webcast on Late-Breaking China Phase 3 Telitacicept Data in Primary Sjgrens Disease
October 22, 2025 16:30 ET | Source: Vor Biopharma CAMBRIDGE, Mass., Oct.…
Aveanna Announces Pricing of Secondary Offering of Common Stock
ATLANTA, Oct. 21, 2025 (GLOBE NEWSWIRE) -- Aveanna Healthcare Holdings Inc. (NASDAQ:…
